Surgical strategies for spontaneous intracerebral hemorrhage: a Bayesian network meta-analysis of randomized controlled trials. [PDF]
Zhou Y, Wei Y, Yu C, Li R, Su C.
europepmc +1 more source
Real-World Outcomes of Aflibercept 2 mg Using a Treat-and-Extend Protocol for Neovascular Age-Related Macular Degeneration: A 24-Month Retrospective Study in a Chinese Population. [PDF]
Qi Y, Cheng A, Xu J, Zhang C, Li S.
europepmc +1 more source
Suprachoroidal Triamcinolone Plus Intravitreal Bevacizumab Versus Bevacizumab Alone for Diabetic Macular Edema in Pseudophakic Eyes: A randomized controlled trial. [PDF]
Ahmad I, Mahsood YJ.
europepmc +1 more source
Visual acuity in controls and patients measured with Maxwellian view and a 3 mm pupil: Examining potential effects of inherent and induced aberrations. [PDF]
Parimi V, Elsner AE, Clark CA, King BJ.
europepmc +1 more source
Metagenomics next-generation sequencing of plasma combined with blood cells for improving the prognosis of early infection in patients with hematologic disorders: a real-world cohort study in northern China. [PDF]
Lyu C +8 more
europepmc +1 more source
Junctions in Jeopardy: the neuromuscular junction is a selective pathological target in Charcot-Marie-Tooth disease. [PDF]
Snape L, Sleigh JN.
europepmc +1 more source
COMPARE COMBINED USE OF ANTI-VEGF DRUGS DURING OR AFTER PARS PLANA VITRECTOMY FOR DIABETIC MACULAR EDEMA GUIDED BY MICROSCOPE-INTEGRATED OPTICAL COHERENCE TOMOGRAPHY. [PDF]
Zhu J, Liu J, Chen YX, Yang XW, Zhu RR.
europepmc +1 more source
Indications and outcome of intravitreal bevacizumab injection in a Community Eye Hospital, Nepal. [PDF]
Thakali S +3 more
europepmc +1 more source
A Case of Advanced Charcot-Marie-Tooth Disease Showing Extreme Lumbosacral Nerve Root Hypertrophy. [PDF]
Lemchak JP +3 more
europepmc +1 more source

